Aldevron vs Pharmaron Biologics: CDMO Comparison

Side-by-side comparison of Aldevron and Pharmaron Biologics on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.

Fargo, ND
Signal Score
85/100
Quality (FDA + GMP)
100/100
FDA inspections
1
— NAI / VAI / OAI
1 / 0 / 0
FDA warning letters
0
EMA GMP certificates (active)
0
MHRA GMP certificates (compliant)
0
Clinical programs (matched)
0
Capacity
Modalities
Plasmid, mRNA
San Diego, CA · Shaoxing, CN
Signal Score
86/100
Quality (FDA + GMP)
100/100
FDA inspections
3
— NAI / VAI / OAI
3 / 0 / 0
FDA warning letters
0
EMA GMP certificates (active)
0
MHRA GMP certificates (compliant)
0
Clinical programs (matched)
0
Capacity
Modalities
AAV, Lentiviral, Plasmid

Key differences

  • Both maintain clean enforcement records — no FDA OAI classifications or warning letters on file for either CDMO.

On a 13-modality CDMO landscape, both Aldevron and Pharmaron Biologics qualify as Plasmid DNA manufacturers; Pharmaron Biologics carries the higher composite Signal Score for Plasmid DNA programs in this comparison.

What to evaluate for Plasmid DNA programs

Both Aldevron and Pharmaron Biologics qualify as Plasmid DNA CDMOs. When choosing between them for Plasmid DNA programs, weigh these four dimensions specifically — each carries through to the side-by-side scorecard above.

GMP grade & purity

Confirm GMP (vs research/HQ) grade, supercoiled percentage, and residual host-cell DNA/RNA and endotoxin specs — these gate downstream vector and mRNA quality.

Fermentation scale & yield

Match fermentation scale and yield to your vector or mRNA demand. Ask about high-yield strains and whether scale-up is validated.

Lead time

Plasmid is a common critical-path bottleneck. Evaluate realistic queue and turnaround against your program timeline.

Regulatory track record

Cross-check FDA 483 history and EMA/MHRA GMP coverage — both shown above and on each profile.

See all Plasmid DNA CDMOs ranked by Signal Score →

Frequently asked: Aldevron vs Pharmaron Biologics

Which has the stronger FDA inspection record, Aldevron or Pharmaron Biologics?

Both Aldevron and Pharmaron Biologics maintain clean enforcement records on file — no FDA warning letters and no OAI classifications. Aldevron has 1 FDA inspection on record; Pharmaron Biologics has 3.

Which is better for Plasmid DNA manufacturing — Aldevron or Pharmaron Biologics?

Both Aldevron and Pharmaron Biologics are tagged as Plasmid DNA CDMOs in our directory, so both are credible options for Plasmid DNA programs. The most important differentiator for Plasmid DNA selection is typically gmp grade & purity: Confirm GMP (vs research/HQ) grade, supercoiled percentage, and residual host-cell DNA/RNA and endotoxin specs — these gate downstream vector and mRNA quality. Review each CDMO's profile and inspection record before shortlisting.

What does the Signal Score gap mean in practice?

Aldevron carries a Signal Score of 85/100 and Pharmaron Biologics carries 86/100 — essentially tied for Pharmaron Biologics. The Signal Score combines quality (FDA inspections + EMA/MHRA GMP), operational performance, financial stability, and capacity intelligence. CDMOs cannot pay to influence their score.

Evaluating Aldevron and Pharmaron Biologics for a program?

Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.

Find & compare CDMOs →
Sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.